Chinese Journal of Gastroenterology 2017;22(9):569-571

doi:10.3969/j.issn.1008-7125.2017.09.013

Progress of Drug Treatment for Gastrointestinal Neuroendocrine Neoplasm

Yandong LI ; Ye WANG ; Shigang DING

Keywords

Neuroendocrine Tumors; Gastrointestinal Tract; Drug Therapy

Country

China

Language

Chinese

Abstract

Neuroendocrine neoplasm (NEN)is a group of heterogeneous tumor originated from the neuroendocrine system,and gastrointestinal neuroendocrine neoplasm (GI-NEN)is the mostly frequently seen. The incidence of GI-NEN is increasing year by year,but the efficacy of clinical treatment is unsatisfactory. In recent years,new progress has been achieved in medical therapy of GI-NEN,including somatostatin analogues,interferon,mTOR inhibitor,vascular endothelial growth factor inhibitor and chemotherapeutic drugs. Peptide receptor radionuclide therapy also provides an additional option for treatment of metastatic GI-NEN. This article reviewed the recent progress of drug treatment for GI-NEN.